In mice, genetic modification of the germline melanoma susceptibility gene Cdkn2a (p16Ink4a null mice) does not result in melanoma, with these mice typically developing soft‐tissue sarcomas and lymphomas 45. This evidence concerns the gene CDKN2A and lymphoma.